Worldwide, it is estimated that **** to **** percent of the global population between 15 and 64 years of age have used opioids in the past year, while approximately **** to **** percent have used amphetamines. This statistic shows the estimated percentage of the global population that have used illicit drugs in the past year as of 2021, by drug type. Substance use and addiction Increased vulnerability to using drugs is highly associated with a lack of education about substances and their consequences. Other main factors include biologic factors such as genetic predisposition and personality traits as well as social and environmental factors including difficult home and school life, abuse and neglect, and social deprivation. However, not all who have used illicit substances become addicted, as there were more than seven times more drug consumers than addicts worldwide in 2021. For those with drug use disorders, treatment varies per substance used, but can include detoxification and control of withdrawal symptoms often using medication, and psychological and behavioral support such as motivational interviewing and cognitive behavioral therapy. Consequences of illicit drug use Furthermore, there are multiple consequences related to drug use. For example, an estimated *** percent of the global population injects drugs, and unsafe injection carries the possibility of spreading blood-borne diseases such as HIV and hepatitis C. In 2020, there were over ** million opioid users worldwide, although there is a high risk of fatal overdose. Impaired driving, as well as drug use while pregnant, are also causes of great concern. Globally, drug use also has additional burdens and costs associated with combating crime, health care, social consequences, and lost productivity.

This report contains results from the latest survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and wellbeing. In 2023 the survey was administered online for the first time, instead of paper-based surveys as in previous years. This move online also meant that completion of the survey could be managed through teacher-led sessions, rather than being conducted by external interviewers. The 2023 survey also introduced additional questions relating to pupils wellbeing. These included how often the pupil felt lonely, felt left out and that they had no-one to talk to. Results of analysis covering these questions have been presented within parts of the report and associated data tables. The report includes this summary report showing key findings, excel tables with more detailed outcomes, technical appendices and a data quality statement. An anonymised record level file of the underlying data on which users can carry out their own analysis will be made available via the UK Data Service in early 2025 (see link below).

In the United States, the percentage of adults who stated they had ever had trouble in their family due to drug abuse rose from 19 percent in 1995 to 32 percent in 2021. This statistic shows the percentage of U.S. adults who reported drug abuse had ever caused trouble in their family from 1995 to 2021.

Marijuana is by far the most used illicit drug in the United States, with over 64 million people using this drug in 2024. The second most used drug at that time was cocaine, followed by methamphetamine and ecstasy. The United States has had a complicated history with drugs, from fighting a “War on Drugs” starting in the 1970s, to seeing the legalisation of marijuana in many states, and experiencing an ongoing nationwide opioid overdose epidemic. Recreational marijuana Although marijuana is still illegal under federal law, 21 states have legalized the recreational use of marijuana. This legalization has opened a new and thriving market in these states. It is estimated that sales of legal cannabis will reach around 25 billion U.S. dollars by the year 2025. Although support for the legalization of marijuana has not always been strong, now around 68 percent of U.S. adults believe it should be made legal. The opioid epidemic The opioid epidemic describes a rise in overdose deaths in the U.S. due to prescription opioids, heroin, and illegally manufactured synthetic opioids such as fentanyl. The epidemic stems from misleading information from pharmaceutical companies concerning the dangers of opioids such as oxycontin, overprescribing of opioids from physicians, and an influx of easily accessible heroin and highly potent synthetic opioids. In 2022, there were around 81,806 deaths from opioid overdose in the United States.

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation http://www.samhsa.gov/data/2k12/NSDUH2008MRB/Index.aspx is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.

As of 2024, 14.5 percent of the adult population in Spain was estimated to have used illicit drugs in the previous year, with this being the highest estimated figure in any European country. The Netherlands had the second-highest rate of illicit drug use, at around 13.7 percent. Examples of problem drug use in Europe According to the latest figures, the Netherlands and France had the highest share of their population who had used cocaine in the previous year in Europe. Around 2.7 percent of the Dutch and French population had used cocaine in the preceding twelve months, followed by Spain and Ireland, which both had over two percent of individuals using cocaine. When it comes to amphetamines, Finland had the highest prevalence of use, with 2.3 percent of their respective populations using in the last year. Drug deaths in Europe In 2021, 54 percent of men who died as a result of drug use in Europe were aged between 25 and 44 years, while 39 percent of drug deaths among women were also in this age group. Estonia was the country in Europe with the highest incidence of drug deaths, at 135 per million population.

The Arrestee Drug Abuse Monitoring (ADAM) Program/Drug Use Forecasting (DUF) Series is an expanded and redesigned version of the Drug Use Forecasting (DUF) program, which was upgraded methodologically and expanded to 35 cities in 1998. The redesign was fully implemented beginning in the first quarter of 2000 using new sampling procedures that improved the quality and generalizability of the data. The DUF program began in 1987 and was designed to estimate the prevalence of drug use among persons in the United States who are arrested and booked, and to detect changes in trends in drug use among this population. The DUF program was a nonexperimental survey of drug use among adult male and female arrestees. In addition to supplying information on self-reported drug use, arrestees also provide a urine specimen, which is screened for the presence of ten illicit drugs. Between 1987 and 1997 the DUF program collected information in 24 sites across the United States, although the number of data collection sites varied slightly from year to year. Data collection took place four times a year (once each calendar quarter) in each site and selection criteria and catchment areas (central city or county) varied from site to site. The original DUF interview instrument (used for the 1987-1994 data and part of the 1995 data) elicited information about the use of 22 drugs. A modified DUF interview instrument (used for part of the 1995 data and all of the 1996-1999 data) included detailed questions about each arrestee's use of 15 drugs. Juvenile data were added in 1991. The ADAM program, redesigned from the DUF program, moved to a probability-based sampling for the adult male population during 2000. The shift to sampling of the adult male population in 2000 required that all 35 sites move to a common catchment area, the county. The ADAM program also implemented a new and expanded adult instrument in the first quarter of 2000, which was used for both the male and female data. The term "arrestee" is used in the documentation, but because no identifying data are collected in the interview setting, the data represent numbers of arrests rather than an unduplicated count of persons arrested. Funding The National Institute of Justice (NIJ) initiated ADAM in 1998 to replace DUF. In 2007, the Office of National Drug Control Policy (ONDCP) initiated ADAM II.

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.

This report presents a range of information on drug use by adults and children drawn together from a variety of sources. It focuses on England only where possible although some statistics are only readily available at GB or UK level or for England and Wales combined. Some of this is new information whilst some has been published previously. The topics covered include: Hospital admissions related to drug misuse. Deaths relating to drug misuse. Prevalence of drug use. Drug dependence and treatment. Drug seizures. Each section provides an overview of the key findings from these sources, as well as providing sources of further information and links to relevant documents and sources. Some of the data have been published previously by NHS Digital. A data visualisation tool at the link below allows users to select hospital admissions related to drug misuse data for any Local Authority (as contained in the data tables), along with time series data from 2013/14. Regional and national comparisons are also provided.

In 2023, there were over ******* people in Italy who needed assistance in public facilities because of their drug addiction, among which roughly ******* were males. Most of the males' primary substances of abuse were opioids, with **** percent, followed by cocaine. This statistic displays the distribution of males treated for drug addiction in public facilities in Italy as of 2023, by primary substance of abuse.

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.

In 2023, there were almost ******* males in Italy who needed assistance in public facilities because of their drug addiction. Lombardy was the Italian region with the highest number of males treated for drug addiction, with almost ******. This statistic displays the number of males treated for drug addiction in public facilities in Italy as of 2023, by region.

Historical Dataset of Department Of Mental Health And Addiction Services School District is provided by PublicSchoolReview and contain statistics on metrics:Comparison of Diversity Score Trends,Hispanic Student Percentage Comparison Over Years (2013-2023),Black Student Percentage Comparison Over Years (2011-2016),White Student Percentage Comparison Over Years (2012-2023)

In 2023, a survey found that among U.S. adults with personal or family addiction experience, white adults more often reported that they or their family member ever got treatment for their drug addiction or substance use disorder.

This statistic portrays the share of adults in the U.S. with personal or family addiction experience who said they or a family member ever got treatment for drug addiction or substance abuse disorder as of 2023, by race and ethnicity.

Find data on heavy drinking and substance use treatment admissions among adults in Massachusetts. These data are presented by race and Hispanic ethnicity.

These data provide information on the relationship between arrestee drug tests and future criminality once other risk factors, such as prior criminal history, are accounted for. Also explored is whether the association between drug test results and future offending varies depending upon the attributes of individual offenders. The dataset contains information drawn from the Pretrial Services Agency (PSA) in Washington, DC, and the National Institute of Justice's Drug Use Forecasting (DUF) program. Data are available from each source for 1989 and 1990 with subsequent arrest data provided by PSA through August 1991. The 1989-1990 data supplied by PSA contain information on criminal history and drug test results taken at the time of arrest. Data provided from the DUF program include drug test results from a sample of persons arrested as well as information obtained from arrestee interviews on items such as family and work status. The combined data contain the arrestees' demographic characteristics, arrest and charge information, prior criminal history, and subsequent offending. Drugs tested for include cocaine, opiates, methadone, PCP, amphetamines, barbiturates, marijuana, methaqualone, Darvon, and Valium. In addition, self-reported information regarding an individual's use of and dependency on these drugs is supplied. Demographic information includes age, sex, income, and employment status. Due to changes in the DUF measurement instrument from 1989 to 1990, the variables contained in the two data files are not completely identical.

This study charted Finnish community sanctions clients' situation in life and alcohol and drug use. Main themes included the problems that arose from the respondents' substance use, their motivation to stop using substances, and their use of social services. Additionally, the data include evaluations of client meeting discussions between community sanctions office employees and clients. The data were collected as part of a research project on the adherence of motivational interviewing in the initial substance abuse setting and its effect on clients' substance abuse harm reduction (the MISA project), funded by the Academy of Finland, Criminal Sanctions Agency and Finnish Foundation for Alcohol Studies. The data consist of a pre-treatment survey, evaluations of counselling session discussions by both the counsellor and the client, post-treatment surveys, and background information surveys for both the client and the employee. The pre-treatment survey, evaluations and background information surveys were completed during the counselling sessions, and the post-treatment surveys were completed as phone interviews six and twelve months after treatment. This dataset can be connected to the qualitative dataset FSD3370 Substance Abuse Treatment in Community Sanctions Offices: Client Meetings 2007-2009, which consists of transcriptions of the counselling session discussions. The respondents in the two datasets can be connected with a unique client number. The qualitative dataset is only available in Finnish. The pre- and post-treatment surveys were nearly identical. First, the clients' situation in life and use of alcohol in the past six months were surveyed with questions from the Alcohol Use Disorders Identification Test (AUDIT). The questions focused on, for example, how often the respondents consumed alcohol, how often they had not been able to stop drinking once they had started, how often they had felt guilt or remorse after drinking, and whether they had felt that their drinking had effected their social relationships negatively. The respondents' substance use was examined with questions regarding which substances they used and which substance was their principal opiate, i.e. for which opiate they were currently receiving treatment. Further questions on substance use were included from the Severity of Dependence Scale (SDS), for example, whether the respondents thought the use of their principal opiate was out of control and whether they wished they could stop using the opiate. Next, the pre-treatment survey charted the respondents' personal objectives regarding their substance use. The respondents were asked, for example, whether their objective was to achieve total abstinence or reduce their use of substances, or whether they though there was no need to change their substance use. Additionally, they were asked how sure they were that they would succeed in achieving their objective. Both the pre- and post-treatment surveys charted whether the respondents had any other addictions in addition to substances (e.g. a gambling, sex, or internet addiction). Finally, the treatment the respondents had received was examined in both surveys with questions on, for example, how many treatment periods they had received for substance use, whether they had received treatment for their substance use in the past six months, and whether they been on any medication to control their substance use in the past three months. They were also asked whether they had found the Behaviour-Interviewing-Change (BIC) program, which was utilised during the client meetings, useful for their substance abuse rehabilitation. For the evaluations of the counselling session discussions, the counsellors and clients were asked to evaluate different aspects of the discussion on a scale from 1 to 5. Both the clients and counsellors were asked, for example, whether they though the discussion had been good or bad, difficult or easy, useful or useless, or significant or insignificant. The client's perception of the attitude of the counsellor was charted with questions on, for example, whether the client thought the counsellor was judgemental or accepting, or unkind or kind. The counsellor's perception of the client's attitude was examined with questions regarding, for example, how much emotion the counsellor thought the client expressed and whether the client was willing or unwilling to work together with the counsellor during the discussion. Finally, the clients were asked to evaluate their own preparedness to stop or reduce substance use, and the counsellors were asked to evaluate whether the client had a strong will to change their behaviour and whether they were likely to continue treatment and reduce or stop substance use. In the background information surveys, additional information on the BIC program and the progress of the client meeting discussions was collected. Additionally, the counsellor's previous experiences of substance abuse care and the BIC program were charted. Background variables included, among others, the client's and counsellor's gender, marital status and level of education.

National Drugs Strategy Household Survey (NDSHS)- Illicit Drugs

Illicit substance use data Any drug = Used at least 1 of 16 illicit drugs in 2016 (Note: the number and type of illicit drug used varied between 1998 and 2016.
Cannabis = Used in the previous 12 months Cocaine = Used in the previous 12 months.
Ecstasy = Used in the previous 12 months. meth/amphetamine used for non-medical purpose in the previous 12 Months. Pain-killers/analgesics and opioids for non-medical purposes Tranquillisers/sleeping pills for non-medical purposes

Steroids for non-medical purposes

OTC refers to paracetamol, aspirin and other non-opioid over-the-counter pain-killers/analgesics.

= Statistically significant change between 2013 and 2016.

• = Estimate has a relative standard error of 25% to 50% and should be used with caution.
  ** = Estimate has a high level of sampling error (relative standard error of 51% to 90%), meaning that it is unsuitable for most uses.
  < = less than (<) the value stated. n.p. = not published Note: For years 2001 to 2010, 'Pain-killers/analgesics and opioids' refers to the combined rates from the 'pain-killer/analgesics' and 'other opiates' sections and may include the use of non-opioid over-the-counter (OTC) drugs such as paracetamol and aspirin. In 2013, a new question was added to the survey and captured the types of prescription and over-the-counter analgesics used allowing the 2013 data to be reanalysed including and excluding non-opioid over-the-counter drugs such as paracetamol and aspirin. In 2016, pain-killer/analgesics and opioids sections were combined into one section and references and questions about use of non-opioid over-the-counter (OTC) drugs such as paracetamol and aspirin were removed. While analyses have been undertaken to make the 2013 and 2016 data as comparable as possible, the changes to the 2016 survey has resulted in a break in the time-series for pain-killers and opiates and also for the overall misuse of pharmaceuticals. As the data are no longer comparable, significance testing was not undertaken between 2013 and 2016 for 'pain-killers/analgesics and opioids' or misuse of any pharmaceutical.

The data is presented by the ACT Government for the purpose of disseminating information for the benefit of the public. The ACT Government has taken great care to ensure the information in this report is as correct and accurate as possible. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. Differences in statistical methods and calculations, data updates and guidelines may result in the information contained in this report varying from previously published information.

Data on received drugs analyzed in DEA Office of Forensic Sciences laboratories. Data is reported by drug type, by state, and by month. The DEA Office of Forensic Sciences oversees decentralized accredited laboratories, which analyze evidence obtained by DEA law enforcement to support investigations. The laboratories use a laboratory information management system (LIMS) to receive, process, analyze and store the data. Before 2013, DEA’s LIMS system was referred to as the System to Retrieve Information on Drug Evidence (STRIDE).

Survey on Homeless Persons: Homeless persons according to whether or not they have been reported and drug use. National.